A Randomised Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Cognitive Enhancing Effect of GSK239512 in Stable Patients With Schizophrenia
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00000857/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
This study aims to evaluate the cognitive enhancing effects and tolerability of GSK239512 compared to placebo in patients with schizophrenia
提供机构:
Vivli
创建时间:
2018-10-27



